Fighting Malaria is Worth Getting Stuck in the Mud

by Alena Sims, Communications and Knowledge Management Associate, Malaria and Child Survival, PSI “I used to give malaria treatment to all patients who had symptoms without properly testing them,” explains Phyu Khin Khine, a community healthcare worker serving 15 rural villages in Myanmar. “And, I would give them bad medications without knowing.” For nearly 17

Read More

Poor Quality Malaria Medicines Continue to Persist in Sub-Saharan Africa

For nine years, PSI’s multi-country research project, ACTwatch, worked to fill evidence gaps in quality of malaria testing and treatment throughout sub-Saharan Africa and the Greater Mekong Sub-region.  Recently, ACTwatch released a new publication series in the Malaria Journal, through which they provide a comprehensive view into the levels of access to quality, first-line malaria

Read More

Using Consumer Marketing Strategies to Transform the Private Market for Malaria Treatment

Lessons Learned from the DRC

By Katie MacDonald, Deputy Chief of Party for DEFEAT Malaria, PSI/ASF More than 11 million malaria cases are reported annually in the Democratic Republic of Congo, making it the second most malaria-affected country in the world. Yet, appropriate malaria diagnosis and treatment is often unavailable, especially in private clinics and pharmacies where over 70% percent

Read More

Transforming Health For All in Angola

By Dr. Paulo R P Souza, chief of party of HFA, PSI/Angola In Angola, nearly two decades of peace and robust economic growth has led to huge progress in the management of the country’s national health system. Building on years of bilateral collaboration, USAID launched Projecto de Saúde Para Todos (Health For All, or HFA)

Read More

Leading with Evidence this Malaria Day

To celebrate World Malaria Day, we’re sharing the article below from BugBitten, the official blog of BioMed Central. Read on for a Q&A with the minds behind ACTwatch, PSI’s multi-country research project designed to fill evidence gaps in malaria. And if you’d like to take a deep dive into the data ACTwatch has collected, check out the

Read More

How to Improve Access to Malaria Treatment in the Private Sector

PSI recently hosted a webinar on how to transform the market for malaria rapid diagnostic tests (mRDTs) in the private sector. Panelists from PSI and four partner organizations, including the World Health Organization (WHO), Foundation for Innovative New Diagnostics (FIND), Johns Hopkins Bloomberg School of Public Health, and Malaria Consortium, dove deep into the lessons

Read More

Upcoming Webinar: Stimulating the Market for Malaria RDTs in the Private Sector

Despite significant reductions in malaria in endemic countries over the past decade, fever is still often presumptively treated as malaria without being properly diagnosed. This leads to overuse of frontline treatment for malaria (ACT) and to the mismanagement of other potentially life-threatening diseases such as pneumonia and diarrhea. The availability of high quality, inexpensive malaria

Read More
malaria

PSI Contributes New Chapter to Springer’s “Encyclopedia of Malaria”

PSI recently published a chapter in Springer Publishing’s “Encyclopedia of Malaria.” “Malaria Diagnostics in the Private Sector” provides the most up-to-date findings and recommendations related to malaria diagnosis in the private health sector. Drawn largely from PSI’s experience implementing the UNITAID funded private sector malaria rapid diagnostics tests (mRDTs) project, the chapter focuses on the

Read More

#TropMed16: Leading with Evidence

By Desmond Chavasse, Senior Vice President, Malaria Control and Child Survival, PSI Every year, the American Society for Tropical Medicine and Hygiene (ASTMH) Annual Meeting provides an opportunity for the malaria community to come together. We celebrate progress made in the fight against malaria, and reexamine the best path towards successful malaria control and elimination. At

Read More

PSI and WHO Create Malaria Testing Roadmap

By Alena Sims, Communications Associate, PSI WHO recommends that every suspected malaria case be confirmed by parasitological testing using microscopy or malaria rapid diagnostic tests (mRDTs) before treatment. The availability of high-quality, inexpensive mRDTs in the public sector has significantly improved and expanded diagnostic testing in the recent past. However, in the private sector, where

Read More

The Business of Malaria

By Alia McKee, Kaylin Fabian and Karen Sommer Shalett Despite recent progress, the Democratic Republic of Congo remains the second most malaria-affected country in the world, with upwards of 10 million cases reported each year. Population Services International (PSI) and its partner network member Association de Santé Familiale (ASF) want to ensure that all Congolese have

Read More

Can We Defeat Malaria?

By Kaleigh Rogers, Reporter, VICE In May, VICE reporter Kaleigh Rogers visited Tanzania to report on malaria, and stopped by the Ithna Asheri clinic in Arusha, where a PSI intervention helped train clinicians and lab techs in using malaria Rapid Diagnostic Tests (mRDTs) to properly diagnosis and treat fever cases. Below are excerpts from her

Read More